In a 58-year-old woman presenting with fever, headache, anemia (hemoglobin 9.4 g/dL), neutrophilic leukocytosis (84% neutrophils), microcytosis (mean corpuscular volume 59.5 fL, mean corpuscular hemoglobin 18.1 pg), low packed cell volume (30.8%), and markedly elevated inflammatory markers (erythrocyte sedimentation rate 82 mm/h, C‑reactive protein 11.5 mg/L), what is the most likely diagnosis and what initial management should be undertaken?

Likely Diagnosis: Combined Iron Deficiency Anemia and Anemia of Chronic Disease

This 58-year-old woman most likely has combined iron deficiency anemia (IDA) and anemia of chronic disease (ACD) secondary to an underlying infectious or inflammatory process, and requires urgent evaluation to identify the source of infection/inflammation while initiating appropriate iron supplementation.

Diagnostic Reasoning

Anemia Classification

The laboratory findings reveal microcytic anemia (MCV 59.5 fL, MCH 18.1 pg, Hb 9.4 g/dL) with markedly elevated inflammatory markers (ESR 82 mm/h, CRP 11.5 mg/L) 1, 2. The microcytosis with low reticulocyte production (implied by the presentation) indicates either iron deficiency, anemia of chronic disease, or both 2.

Iron Status Interpretation

Critical diagnostic point: In the presence of inflammation (elevated CRP and ESR), ferritin levels up to 100 μg/L may still be consistent with iron deficiency 2, 3, 4. Without a reported ferritin level in this case, but given the severe microcytosis (MCV 59.5 fL) and low MCH (18.1 pg), iron deficiency is highly probable even if ferritin appears "normal" 2.

The combination of:

• Severe microcytosis (MCV <60 fL)
• Marked elevation in inflammatory markers
• Neutrophilic leukocytosis (84% neutrophils)

...suggests overlapping IDA and ACD 2.

Underlying Cause: Acute Infection

The fever (101°F), headache, neutrophilic leukocytosis (84%), and markedly elevated inflammatory markers point to an active infectious or inflammatory process requiring immediate investigation 5, 6.

Priority Differential Diagnoses to Exclude:

1. Bacterial infection (most urgent):

   • Urinary tract infection/pyelonephritis
   • Pneumonia
   • Intra-abdominal infection
   • Meningitis (given headache) 5

2. Occult malignancy with infection (given age and chronic anemia)

3. Inflammatory bowel disease (can cause both IDA and systemic inflammation) 2

4. Other chronic inflammatory conditions

Immediate Management Algorithm

Step 1: Urgent Infectious Workup (Within Hours)

• Blood cultures (before antibiotics)
• Urinalysis and urine culture
• Chest X-ray
• If headache with altered mental status or focal neurologic signs: Consider lumbar puncture after imaging to exclude meningitis 5
• Procalcitonin (if available) to assess bacterial infection likelihood

Step 2: Complete Anemia Evaluation (Concurrent)

Minimum required tests 2, 3:

• Serum ferritin
• Transferrin saturation (TSAT)
• Reticulocyte count (to confirm hypoproliferative anemia)
• Peripheral blood smear (to assess RBC morphology and exclude other causes)
• Stool guaiac (to exclude GI bleeding as iron loss source) 1

Interpretation criteria 2, 3:

• If ferritin <30 μg/L without inflammation: Iron deficiency confirmed
• If ferritin 30-100 μg/L with inflammation (CRP >5 mg/L): Combined IDA + ACD likely
• If ferritin >100 μg/L with TSAT <20%: Pure ACD

Step 3: Additional Testing Based on Clinical Context

• Vitamin B12 and folate (though less likely given microcytosis) 1, 2
• Renal function (creatinine, BUN) to exclude renal anemia contribution 1
• Hemoglobin electrophoresis if family history or ethnicity suggests thalassemia (though severe microcytosis with anemia makes thalassemia trait less likely) 1, 7

Step 4: Source Control and Antimicrobial Therapy

• Empirical broad-spectrum antibiotics if sepsis suspected (after cultures obtained)
• Targeted therapy once source identified
• Address underlying inflammatory condition (e.g., IBD treatment if diagnosed)

Step 5: Iron Supplementation

Iron replacement is indicated once iron deficiency is confirmed 2, 4:

• Intravenous iron preferred in presence of active inflammation (better absorption, faster response) 2

  • Total dose: 1000-1500 mg for Hb 7-10 g/dL, body weight <70 kg 2
  • Total dose: 1500-2000 mg for Hb 7-10 g/dL, body weight ≥70 kg 2

• Oral iron (ferrous sulfate 325 mg daily) acceptable if:

  • Mild inflammation
  • Patient tolerates oral therapy
  • No urgent need for rapid correction 2

Target response: Hemoglobin increase ≥2 g/dL within 4 weeks 2

Critical Pitfalls to Avoid

1. Do not assume "normal" ferritin excludes iron deficiency in the setting of inflammation – ferritin is an acute phase reactant and can be falsely elevated 2, 3

2. Do not delay infectious workup – fever with neutrophilia requires urgent evaluation regardless of anemia 5, 6

3. Do not overlook occult GI bleeding – microcytic anemia in a 58-year-old woman warrants GI evaluation even with menstrual history 1

4. Do not transfuse unless symptomatic or hemodynamically unstable – Hb 9.4 g/dL typically does not require transfusion in stable patients 8

5. Do not attribute all findings to iron deficiency alone – the marked inflammatory response suggests an active underlying process requiring treatment 2

Prognosis and Follow-up

Expected timeline:

• Fever should resolve with treatment of underlying infection
• Hemoglobin should increase ≥2 g/dL within 4 weeks of iron therapy 2
• Inflammatory markers should normalize with source control
• Recheck CBC, ferritin, CRP at 4 weeks to assess response 2

If anemia persists despite treatment: Consider hematology referral for bone marrow evaluation to exclude primary marrow disorder 1, 2.